Baldicantos, Baby Boy .
HRN: 24-25-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/23/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/23/2023
12/29/2023
IV
45mg
OD
Potentially Septic Newborn
Checking Final Appropriateness
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes